Researchers at the University of South Australia have developed a novel, biodegradable gel for Parkinson's disease treatment.

An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

If every pharma company had this, they would have much greater access to their medications without people in the middle." In ...

A study reveals a brain circuit between the interpeduncular nucleus and the laterodorsal tegmentum that drives nicotine ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with ...

Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment of bipolar disorder ...

Australian scientists have developed a weekly injectable for Parkinson’s that delivers steady medication, potentially replacing daily pills and improving treatment consistency and quality of life.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).

An Ozempic user has revealed what they believe is a 'terrifying' side effect of upping their Ozempic dose. Falling into the category of GLP-1 medications, Ozempic is FDA-approved for type two diabetes ...

A World Health Organisation (WHO) report released this week has some ideas on how to fight Big Tobacco's influence machine — just as an SA Bill regulating newer tobacco products has finally reached ...

The FDA tracks and often takes measures to warn consumers of both Tianpetine and Kratom-based products, like 7-Hydroxymitragynine. Gas stations sell both, despite the FDA’s efforts to deter the ...

Researchers in Australia have created a biodegradable gel that delivers Parkinson’s medications through a single weekly shot, ...